Literature DB >> 34201889

Performance of Integrated Near-Infrared Spectroscopy and Intravascular Ultrasound (NIRS-IVUS) System against Quantitative Flow Ratio (QFR).

Magdalena M Dobrolińska1, Paweł M Gąsior1, Elżbieta Pociask2, Grzegorz Smolka1, Andrzej Ochala1, Wojciech Wojakowski1, Tomasz Roleder3.   

Abstract

Quantitative flow ratio (QFR) is a new opportunity to analyze functional stenosis during invasive coronary angiography. Together with a well-known intravascular ultrasound (IVUS) and a new player in the field, near-infrared spectroscopy (NIRS), it is gaining a lot of interest. The aim of the study was to compare QFR results with integrated IVUS-NIRS results acquired simultaneously in the same coronary lesion. We retrospectively enrolled 66 patients in whom 66 coronary lesions were assessed by NIRS-IVUS and QFR. Lesions were divided into two groups based on QFR results as QFR-positive group (QFR ≤ 0.8) or QFR-negative group (QFR > 0.8). Based on ROC curve analysis, the best cut-off values of minimal lumen area (MLA), minimal lumen diameter (MLD) and percent diameter stenosis for predicting QFR ≤ 80 were 2.4 (AUC 0.733, 95%CI 0.61, 0.834), 1.6 (AUC 0.768, 95%CI 0.634, 0.872) and 59.5 (AUC 0.918, 95%CI 0.824, 0.971), respectively. In QFR-positive lesions, the maxLCBI4mm was significantly higher than in QFR-negative lesions (450.12 ± 251.0 vs. 329.47 ± 191.14, p = 0.046). The major finding of the present study is that values of IVUS-MLA, IVUS-MLD and percent diameter stenosis show a good efficiency in predicting QFR ≤ 0.80. Moreover, QFR-positive lesions are characterized by higher maxLCBI4mm as compared to the QFR-negative group.

Entities:  

Keywords:  coronary artery disease; intravascular ultrasound; ischemia; near-infrared spectroscopy; quantitative flow ratio

Year:  2021        PMID: 34201889     DOI: 10.3390/diagnostics11071148

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  25 in total

1.  Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.

Authors:  Frederik M Zimmermann; Angela Ferrara; Nils P Johnson; Lokien X van Nunen; Javier Escaned; Per Albertsson; Raimund Erbel; Victor Legrand; Hyeong-Cheol Gwon; Wouter S Remkes; Pieter R Stella; Pepijn van Schaardenburgh; G Jan Willem Bech; Bernard De Bruyne; Nico H J Pijls
Journal:  Eur Heart J       Date:  2015-09-23       Impact factor: 29.983

2.  Validation of intravascular ultrasound-derived parameters with fractional flow reserve for assessment of coronary stenosis severity.

Authors:  Soo-Jin Kang; Jong-Young Lee; Jung-Min Ahn; Gary S Mintz; Won-Jang Kim; Duk-Woo Park; Sung-Cheol Yun; Seung-Whan Lee; Young-Hak Kim; Cheol Whan Lee; Seong-Wook Park; Seung-Jung Park
Journal:  Circ Cardiovasc Interv       Date:  2011-01-25       Impact factor: 6.546

3.  Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era.

Authors:  Helen Parise; Akiko Maehara; Gregg W Stone; Martin B Leon; Gary S Mintz
Journal:  Am J Cardiol       Date:  2011-02-01       Impact factor: 2.778

4.  Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease.

Authors:  Rohit M Oemrawsingh; Jin M Cheng; Héctor M García-García; Robert-Jan van Geuns; Sanneke P M de Boer; Cihan Simsek; Isabella Kardys; Mattie J Lenzen; Ron T van Domburg; Evelyn Regar; Patrick W Serruys; K Martijn Akkerhuis; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

5.  Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study.

Authors:  David Erlinge; Akiko Maehara; Ori Ben-Yehuda; Hans Erik Bøtker; Michael Maeng; Lars Kjøller-Hansen; Thomas Engstrøm; Mitsuaki Matsumura; Aaron Crowley; Ovidiu Dressler; Gary S Mintz; Ole Fröbert; Jonas Persson; Rune Wiseth; Alf Inge Larsen; Lisette Okkels Jensen; Jan Erik Nordrehaug; Øyvind Bleie; Elmir Omerovic; Claes Held; Stefan K James; Ziad A Ali; James E Muller; Gregg W Stone
Journal:  Lancet       Date:  2021-03-13       Impact factor: 79.321

6.  Correction.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2015-07-13       Impact factor: 24.094

7.  In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study.

Authors:  Sergio Waxman; Simon R Dixon; Philippe L'Allier; Jeffrey W Moses; John L Petersen; Donald Cutlip; Jean-Claude Tardif; Richard W Nesto; James E Muller; Michael J Hendricks; Stephen T Sum; Craig M Gardner; James A Goldstein; Gregg W Stone; Mitchell W Krucoff
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

8.  Pathological mechanisms of fatal late coronary stent thrombosis in humans.

Authors:  Andrew Farb; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

9.  Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.

Authors:  Lokien X van Nunen; Frederik M Zimmermann; Pim A L Tonino; Emanuele Barbato; Andreas Baumbach; Thomas Engstrøm; Volker Klauss; Philip A MacCarthy; Ganesh Manoharan; Keith G Oldroyd; Peter N Ver Lee; Marcel Van't Veer; William F Fearon; Bernard De Bruyne; Nico H J Pijls
Journal:  Lancet       Date:  2015-08-30       Impact factor: 79.321

10.  Meta-Analysis of Diagnostic Performance of Instantaneous Wave-Free Ratio versus Quantitative Flow Ratio for Detecting the Functional Significance of Coronary Stenosis.

Authors:  Wenjie Zuo; Mingming Yang; Yifan Chen; Aiming Xie; Lijuan Chen; Genshan Ma
Journal:  Biomed Res Int       Date:  2019-04-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.